US 10087169
Bicyclic PKM2 activators
granted A61PA61P35/00A61P43/00
Quick answer
US patent 10087169 (Bicyclic PKM2 activators) held by Agios Pharmaceuticals, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P35/00, A61P43/00